Publisher
Springer Science and Business Media LLC
Reference19 articles.
1. National Isotope Development Center. (November 17, 2022). Introducing a new isotope supply chain to the global market: cerium-134. Accessed April 17, 2024. https://www.isotopes.gov/now_available_Cerium134.
2. Lubberink M, Lundqvist H, Tolmachev V, Production. PET performance and dosimetric considerations of 134Ce/134La, an Auger electron and positron-emitting generator for radionuclide therapy. Phys Med Biol. 2002;47:615–29. https://doi.org/10.1088/0031-9155/47/4/305.
3. Longtine M, Shim K, Abou D, Summer L, Voller T, Thorek D, Wahl R. Initial evaluation of cerium-134 (134Ce) for immunoPET. J Nucl Med. 2022;63:2578.
4. Greenwood RC, Gehrke RJ, Helmer RG, Reich CW, Baker JD. Gamma-ray emission from 134Ce and levels in 134La. Nucl Phys A. 1976;270:29–44. https://doi.org/10.1016/0375-9474(76)90125-1.
5. Bobba KN, Bidkar AP, Wadhwa A, Meher N, Drona S, Sorlin AM, et al. Development of CD46 targeted alpha theranostics in prostate cancer using 134Ce/225Ac-Macropa-PEG4-YS5. Theranostics. 2024;14:1344–60. https://doi.org/10.7150/thno.92742.